Allergic Reaction General Adult Assessment No (Mild) Evidence of anaphylaxis? Yes (Moderate/Severe) A Vascular Access EPINEPHRINE E Assist patient with own auto-injector EPINEPHRINE 1:1000, 0.5 mg IM; A DIPHENHYDRAMINE may repeat q 15 min A 50 mg IM/IV/IO/PO up to max 1.5 mg ALBUTEROL Reassess patient q 5 min E Assist patient with MDI ALBUTEROL 2.5 mg in 3 ml SVN, repeat as needed A OR; LEVALBUTEROL 1.25 mg SVN, repeat as needed Ventilation Management P Cardiac monitor Allergic Reaction – mild immune response to an allergen with symptoms such as hives or local swelling/itching. Vascular access 500 ml NS or LR bolus IV/IO; Anaphylaxis – moderate/severe reaction meeting either of these A may repeat up to 2000 ml criteria: DIPHENHYDRAMINE • Exposure to known or likely allergen with hypotension OR 50 mg IM/IV/IO/PO respiratory compromise • Two or more of the following after exposure to likely allergen: skin/mucosal changes (hives, flushing, edema); Pt in persistent shock? If Yes, then respiratory compromise (SOB, wheezing, stridor, hypoxia); hypotension or signs of shock; persistent GI symptoms (abdominal pain, vomiting) PUSH DOSE EPINEPHRINE 1:100,000 10 mcg IV/IO, may repeat P q 2-5 min to maintain SBP>90 ( 1 ml of 1:100,000 Solution) Continue General Adult Assessment Allergic Reaction Protocol (Revised and approved by MAB 10/2/2024) 17